<p>Have increased knowledge regarding the</p>
<p>Latest data on use of non-vitamin K antagonist oral anticoagulants in the setting of cancer-associated thrombosis</p>

<p>Have greater competence related to</p>
<p>Risk assessment for venous thromboembolism (VTE) recurrence in patients with cancer</p>
<p>Strategies to tailor long-term VTE treatment strategies in patients with cancer</p>
